359 related articles for article (PubMed ID: 9450622)
1. Matrix metalloproteinases in skin.
Kähäri VM; Saarialho-Kere U
Exp Dermatol; 1997 Oct; 6(5):199-213. PubMed ID: 9450622
[TBL] [Abstract][Full Text] [Related]
2. Matrix metalloproteinases in tumor progression: focus on basal and squamous cell skin cancer.
Kerkelä E; Saarialho-Kere U
Exp Dermatol; 2003 Apr; 12(2):109-25. PubMed ID: 12702139
[TBL] [Abstract][Full Text] [Related]
3. Matrix metalloproteinases in squamous cell carcinoma.
Johansson N; Kähäri VM
Histol Histopathol; 2000 Jan; 15(1):225-37. PubMed ID: 10668212
[TBL] [Abstract][Full Text] [Related]
4. Collagenases and tissue inhibitors of metalloproteinases: a functional balance in tissue degradation.
Reynolds JJ
Oral Dis; 1996 Mar; 2(1):70-6. PubMed ID: 8957940
[TBL] [Abstract][Full Text] [Related]
5. Complex role of matrix metalloproteinases in angiogenesis.
Sang QX
Cell Res; 1998 Sep; 8(3):171-7. PubMed ID: 9791730
[TBL] [Abstract][Full Text] [Related]
6. [Extracellular matrix -- from basic research to clinical significance. An overview with special consideration of matrix metalloproteinases].
Hamacher S; Matern S; Roeb E
Dtsch Med Wochenschr; 2004 Sep; 129(38):1976-80. PubMed ID: 15375740
[TBL] [Abstract][Full Text] [Related]
7. Tissue inhibitors of matrix metalloproteinases in cancer.
Blavier L; Henriet P; Imren S; Declerck YA
Ann N Y Acad Sci; 1999 Jun; 878():108-19. PubMed ID: 10415723
[TBL] [Abstract][Full Text] [Related]
8. Stromelysin-3 (ST-3): immunohistochemical characterization of the matrix metalloproteinase (MMP)-11 in benign and malignant skin tumours and other skin disorders.
Thewes M; Worret WI; Engst R; Ring J
Clin Exp Dermatol; 1999 Mar; 24(2):122-6. PubMed ID: 10233668
[TBL] [Abstract][Full Text] [Related]
9. [Focalized matrix proteolysis and inflammation].
Gaudin P; Trocmé C; Monier F; Zaoui P; Barro C; Polack B; Hadjian A; Berthier S; Morel F
Ann Biol Clin (Paris); 1998; 56(6):661-9. PubMed ID: 9853025
[TBL] [Abstract][Full Text] [Related]
10. Human dermal microvascular endothelial cells produce matrix metalloproteinases in response to angiogenic factors and migration.
Cornelius LA; Nehring LC; Roby JD; Parks WC; Welgus HG
J Invest Dermatol; 1995 Aug; 105(2):170-6. PubMed ID: 7543547
[TBL] [Abstract][Full Text] [Related]
11. Matrix metalloproteinase inhibitors.
Wojtowicz-Praga SM; Dickson RB; Hawkins MJ
Invest New Drugs; 1997; 15(1):61-75. PubMed ID: 9195290
[TBL] [Abstract][Full Text] [Related]
12. [Role of matrix-degrading enzymes in melanoma progression].
Hofmann UB; Becker JC; Bröcker EB
Hautarzt; 2002 Sep; 53(9):587-95. PubMed ID: 12207262
[TBL] [Abstract][Full Text] [Related]
13. Matrix metalloproteinases (MMPs) and their physiological inhibitors (TIMPs) are differentially expressed during excisional skin wound repair.
Madlener M; Parks WC; Werner S
Exp Cell Res; 1998 Jul; 242(1):201-10. PubMed ID: 9665817
[TBL] [Abstract][Full Text] [Related]
14. Matrix metalloproteinases involvement in pathologic conditions.
Amălinei C; Căruntu ID; Giuşcă SE; Bălan RA
Rom J Morphol Embryol; 2010; 51(2):215-28. PubMed ID: 20495735
[TBL] [Abstract][Full Text] [Related]
15. Matrix metalloproteinases and their expression in mammary gland.
Uria JA; Werb Z
Cell Res; 1998 Sep; 8(3):187-94. PubMed ID: 9791732
[TBL] [Abstract][Full Text] [Related]
16. Expression of MMPS, MT-MMP, and TIMPs in squamous cell carcinoma of the oral cavity: correlations with tumor invasion and metastasis.
Kurahara S; Shinohara M; Ikebe T; Nakamura S; Beppu M; Hiraki A; Takeuchi H; Shirasuna K
Head Neck; 1999 Oct; 21(7):627-38. PubMed ID: 10487950
[TBL] [Abstract][Full Text] [Related]
17. Role of matrix metalloproteinases in melanoma cell invasion.
Hofmann UB; Houben R; Bröcker EB; Becker JC
Biochimie; 2005; 87(3-4):307-14. PubMed ID: 15781317
[TBL] [Abstract][Full Text] [Related]
18. Matrix metalloproteinases. Novel targets for directed cancer therapy.
Yu AE; Hewitt RE; Connor EW; Stetler-Stevenson WG
Drugs Aging; 1997 Sep; 11(3):229-44. PubMed ID: 9303281
[TBL] [Abstract][Full Text] [Related]
19. The membrane tethered matrix metalloproteinase MT1-MMP at the forefront of melanoma cell invasion and metastasis.
Thakur V; Bedogni B
Pharmacol Res; 2016 Sep; 111():17-22. PubMed ID: 27221755
[TBL] [Abstract][Full Text] [Related]
20. Tissue inhibitors of metalloproteinases (TIMPs): their biological functions and involvement in oral disease.
Verstappen J; Von den Hoff JW
J Dent Res; 2006 Dec; 85(12):1074-84. PubMed ID: 17122157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
